Promoting good mental health over the menopause transition.

Journal: Lancet (London, England)

Volume: 403

Issue: 10430

Year of Publication: 2024

Affiliated Institutions:  Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia; Academic Research Collaborative in Health, La Trobe University, Bundoora, VIC, Australia; Healthscope Hospitals, Melbourne, VIC, Australia. Electronic address: lydia.brown@unimelb.edu.au. Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, China. Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, USA. Department of Psychology, University of Regina, Regina, SK, Canada. NHMRC Centre for Research Excellence in Women and NCDs, School of Public Health, University of Queensland, Brisbane, QLD, Australia. Inner West Area Mental Health Service, Royal Melbourne Hospital, Melbourne, VIC, Australia. Connors Center for Women's Health and Gender Biology and Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and the Royal Women's Hospital, Melbourne, VIC, Australia.

Abstract summary 

The potential risk for mental health conditions over the menopause transition shapes women's expectations and informs putative physiological mechanisms regulating women's mental health. We review evidence from prospective studies reporting on associations between mental health conditions and the menopause transition. Major depressive disorder and the more prevalent subthreshold depressive symptoms are the most common conditions studied. We reviewed 12 prospective studies reporting depressive symptoms, major depressive disorder, or both over the menopause transition and found no compelling evidence for a universal increased risk for either condition. However, specific subgroups of participants, primarily defined by menopause-related risk factors (ie, vasomotor symptoms that are severe or disturb sleep, a long duration of the transition, or reproductive hormone dynamics) and psychosocial risk factors (eg, stressful life events), were vulnerable to depressive symptoms. The increased risk of major depressive disorder over the menopause transition appears predominantly in individuals with previous major depressive disorder. Greater focus on recognising risk factors in primary care is warranted. On the basis of scarce data, we found no compelling evidence that risk of anxiety, bipolar disorder, or psychosis is universally elevated over the menopause transition. Potential misattribution of psychological distress and psychiatric disorders to menopause could harm women by delaying accurate diagnosis and the initiation of effective psychotropic treatments, and by creating negative expectations for people approaching menopause. A paradigm shift is needed. We conclude with recommendations for the detection and treatment of depressive symptoms or major depressive disorder and strategies to promote good mental health over the menopause transition, while responsibly preparing and supporting those at risk.

Authors & Co-authors:  Brown Hunter Chen Crandall Gordon Mishra Rother Joffe Hickey

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  9
Identifiers
Doi : 10.1016/S0140-6736(23)02801-5
SSN : 1474-547X
Study Population
Women,Female
Mesh Terms
Female
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
England